arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

ACCURAY INC

ARAY
$0.23 0.00 (-2.17%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
15
Health
Poor
Bearish
auto_awesome

Analytical Summary

ACCURAY INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $28.2M
Dividend Yield —
Revenue Growth -12.3% ↘
Op. Margin -6.6% ↘
ROIC -14.5% ↘
FCF / Share $-0.10 ↘
Trailing P/E —
Price / Book 0.7x
FCF Yield —
Debt / Equity 3.55
info Valuation on last close. End-of-day price, Sep 23, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$401.95M
↓ -12.3% —
Net Income Profit after all expenses
$-49.19M
↓ -2992.0% —
Operating Margin Operating profit as % of sales
-6.6%
↓ -484.8% 14th
FCF / Share Free cash flow per share
$-0.10
↓ -662.2% —
Long-Term Debt Long-term obligations
$147.87M
↑ +8.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
12
Returns ↓
6
Financial Health →
23
Cash Quality ↓
28

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 18 years · 66 quarters